G. Boxer

发表

Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.

C. Springer, S. Sharma, L. Davies, 1999, Cancer research.

Clinical Applications of Phage-Derived sFvs and sFv Fusion Proteins

K. Chester, S. Sharma, D. Spencer, 2002, Disease markers.

Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear--quadratic formulation.

R. Pedley, R. Begent, A. Green, 2001, International journal of radiation biology.

Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour

R. Pedley, R. Morris, R. Begent, 2002, International journal of radiation biology.

Immunohistochemical Expression of Vascular Endothelial Growth Factor and Microvessel Counting as Prognostic Indicators in Node-Negative Colorectal Cancer

G. Boxer, R. Begent, E. Tsiompanou, 2000, Tumor Biology.

A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.

D. Spencer, R. Begent, L. Lawrence, 2001, Cancer research.

Immunohistological distribution of 5T4 antigen in normal and malignant tissues.

P. Stern, K. Bagshawe, P. Stern, 1990, British Journal of Cancer.

CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells.

A. Forbes, I. Talbot, K. Chester, 1993, European journal of cancer.

Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome

A. Green, G. Boxer, A. Flynn, 1999, British Journal of Cancer.

Identification of a human ribosomal protein mRNA with increased expression in colorectal tumours.

I. Talbot, R. Begent, J. Pringle, 1989, Biochimica et biophysica acta.

Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.

S. Sharma, K. Bagshawe, G. Boxer, 1991, The British journal of radiology.

Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.

R. Pedley, P. Keep, J. Boden, 1996, Cancer research.

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.

R. Pedley, J. Boden, A. Green, 1989, British Journal of Cancer.

Theeffect ofserumCEA on thedistribution andclearance ofanti-CEA antibody ina pancreatic tumourxenograft model

R. Pedley, J. Boden, A. Green, 1989 .

Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues.

M. Taylor, G. Boxer, K. Bagshawe, 1988, British Journal of Cancer.

Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus.

R. Fisher, F. Paradinas, G. Boxer, 1992, British Journal of Cancer.

Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues.

K. Bagshawe, G. Boxer, F. Paradinas, 1984, Journal of clinical pathology.

Orcein as a mucin stain for gastrointestinal tissue sections.

S. Shousha, G. Boxer, 1981, Journal of clinical pathology.

A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.

K. Bagshawe, B. Pedley, J. Boden, 1987, British Journal of Cancer.

Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.

R. Pedley, D. Chaplin, R. Begent, 2001, Cancer research.

Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.

K. Bagshawe, R. Pedley, J. Boden, 1991, The British journal of radiology.

Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.

K. Bagshawe, R. Pedley, J. Boden, 1990, British Journal of Cancer.

A Mouse Model for Calculating the Absorbed Beta-Particle Dose from 131I- and 90Y-Labeled Immunoconjugates, Including a Method for Dealing with Heterogeneity in Kidney and Tumor

A J Green, R. Pedley, R B Pedley, 2001, Radiation research.

Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.

R. Pedley, A. Green, G. Boxer, 2001, Cancer biotherapy & radiopharmaceuticals.

A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model.

J. L. Casey, R. Pedley, A. Green, 1999, International journal of radiation oncology, biology, physics.

In situ and slot hybridization analysis of RNA in colorectal tumours and normal colon shows distinct distributions of mitochondrial sequences

I. Talbot, L. Primrose, K. Chester, 1990, The Journal of pathology.

Phage libraries for generation of clinically useful antibodies

O. Cochet, R. Begent, K. Chester, 1994, The Lancet.

Filamentous phage antibodies: the power of selection for clinical use. In: New Antibody technology and the Emergence of Useful Cancer Therapy.

Joan A. Boden, Ka Chester, Rhj Begent, 1994 .

Br. J. Cancer

J. Ledermann, J. Ledermann, R. Begent, 1991 .

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models

R. Begent, E. Trachsel, A. Huhalov, 2007, British Journal of Cancer.

Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.

R. Pedley, R. Begent, G. Boxer, 1994, British Journal of Cancer.

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models

G. V. van Dongen, M. Robson, G. Boxer, 2007, British Journal of Cancer.